Retrospective Analysis of the Neonatal Management of Patients with an Antenatal Diagnosis of Genital Development Variation At the Hospital of Lyon
NCT ID: NCT06687252
Last Updated: 2024-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
170 participants
OBSERVATIONAL
2023-10-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The value of multidisciplinary management has already been demonstrated, but a number of grey areas remain: the frequency of false-positive ultrasound findings, the place of invasive antenatal diagnostic tests, the role left to parents during the diagnostic process, the frequency of associated malformations discovered post-natally, and how to prepare for immediate management at birth.
The aim of this study is to improve the management of patients and their families as soon as a Disorders of Sexual Development is detected antenatally.
The primary objective is to describe the management, particularly complementary investigations performed in the antenatal management of ultrasound diagnoses of Disorders of Sexual Development over the last 10 years.
The secondary objectives are :
* To determine the correlation between pre- and post-natal morphological phenotype and the proportion of false positives in antenatal ultrasound diagnosis.
* To characterize prenatally diagnosed Disorders of Sexual Development
* To determine the proportion of isolated prenatally-diagnosed Disorders of Sexual Development that turn out not to be isolated during postnatal follow-up.
* The evaluation of the care pathway :
* To establish the frequency of prenatal psychological support for parents
* To establish the role of parents in prenatal diagnosis strategy decisions at our center
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Children in Whom a Prenatal Exome Was Performed Based on Ultrasound Findings
NCT07342933
Embryo Aneuploidies and Ovarian Stimulation
NCT00707525
Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans
NCT02171845
Study of Abnormally Fertilized Embryos
NCT06940973
Efficiency of Comprehensive Chromosomal Testing of Trophectoderm Biopsies of Blastocysts in In Vitro Fertilization
NCT04758819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All fetuses referred to the HFME and Croix Rousse CPDPNs for antenatal diagnostic consultation (DAN)
Non-interventional retrospective study, only on datas for suspected isolated variation in genital development (VDG)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Intrauterine growth retardation (RCIU), a muscular or minor ventricular septal defect, or a pyloric dilatation are not considered as an associated malformation.
Exclusion Criteria
* Lack of data and identification of the child born.
* Referred to CPDPN for urinary malformation including no VDG.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service d'endocrinologie pédiatrique HFME
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL23_5313
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.